TORONTO, March 30 /CNW/ - Bayer Inc. (Bayer), in consultation with Health Canada, has informed health care professionals of new safety information regarding the drug Trasylol(R) (aprotinin). Trasylol(R) is a drug injected during heart bypass surgery to help reduce bleeding and the need for blood transfusions.
